Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin
Authors:
Open Access
- 21 February 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (3) , 577-582
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent PathwayCirculation, 2006
- Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteersJournal of Thrombosis and Haemostasis, 2006
- P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agentsThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006
- Overestimation of Platelet Aspirin Resistance Detection by Thrombelastograph Platelet Mapping and Validation by Conventional Aggregometry Using Arachidonic Acid StimulationJACC, 2005
- The Platelet P2 Receptors in ThrombosisSeminars in Thrombosis and Hemostasis, 2005
- The P2 Receptors in Platelet FunctionSeminars in Thrombosis and Hemostasis, 2005
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Activation of Rap1B by Gi Family Members in PlateletsJournal of Biological Chemistry, 2002
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989